Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“Another MSC-secreted pro-metastasis cytokine, CCL5 (RANTES), can be secreted upon interaction with cancer cells and is associated with tumor progression and invasion in various cancers [73, 87, 100, 142–144].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“The injection of bone marrow-derived MSCs into tumour-bearing mice has demonstrated that they can become CAFs40”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [40]
In the citing paper
“CAFs comprise the majority of cell types within the TME, and their reciprocal interactions with cancer cells have been well documented (Whiteside, 2008; Hazlehurst et al., 2003; Karnoub et al., 2007).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Karnoub et al., 2007
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Self-citationHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Self-citation
Cited by
Items 201–300 of 1,024
Brennen, W. N., Isaacs, J. T., & Denmeade, S. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0340 · Cited by 289
“Bone marrow– derived mesenchymal stem cells, which are known to localize to malignant tissues where they have the ability to differentiate into CAFs or myofibroblast-like cells, have been shown to enhance the metastatic spread of breast cancer cells up to 7-fold (15).”
BackgroundTumor microenvironment promotes breast cancer chemoresistance
Mehraj, U., Dar, A. H., Wani, N. A., & Mir, M. A. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04222-w · Cited by 289
“Breast cancer xenograft studies revealed that BM-derived MSCs stimulate angiogenesis, cancer stemness, and promote metastasis and invasion cascades [63, 64].”
BackgroundLee, C. H., Shah, B., Moioli, E. K., & Mao, J. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43230 · Cited by 289
“Despite their presence in the early stage of wound, α-SMA+ myofibroblasts disappear, presumably by apoptosis, as wound healing progresses (1, 2, 4, 5).”
BackgroundMesenchymal stem cell-based drug delivery strategy: from cells to biomimetic
Wu, H.-H., Zhou, Y., Tabata, Y., & Gao, J.-Q. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.019 · Cited by 288
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., et al. (2022) · Cancer Communications · doi:10.1002/cac2.12291 · Cited by 286
“[56] injected bone marrow-derived MSCs into breast cancer-bearing mice and found that they became CAFs and promoted breast cancer metastasis by inducing paracrine signaling of the chemokine CCL5.”
BackgroundCastells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 285
“Such MSCs are found to stimulate tumor growth, enhance angiogenesis and promote metastasis formation through the release of a large spectrum of growth factors and cytokines [3,85,86].”
BackgroundTorsvik, A., Røsland, G. V., Svendsen, A., Molven, A., Immervoll, H., McCormack, E., Lønning, P. E., Primon, M., Sobala, E., Tonn, J.-C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1305 · Cited by 284
“Furthermore, several reports show that MSC may support tumor growth and development of metastasis in vivo (5, 6).”
BackgroundCCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
Velasco-Velázquez, M., Jiao, X., De La Fuente, M., Pestell, T. G., Ertel, A., Lisanti, M. P., & Pestell, R. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3917 · Cited by 282
“CCL5 can be expressed and secreted either by breast cancer cells (9–12) or by nonmalignant stromal cells at the primary or metastatic sites (13).”
BackgroundInfluentialDiscrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma
Yamashita, T., Honda, M., Nakamoto, Y., Baba, M., Nio, K., Hara, Y., Zeng, S. S., Hayashi, T., Kondo, M., Takatori, H., et al. (2013) · Hepatology · doi:10.1002/hep.26168 · Cited by 281
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 281
Lee, C. H., Shah, B., Moioli, E. K., & Mao, J. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci84508 · Cited by 280
“Despite their presence in the early stage of wound, α-SMA+ myofibroblasts disappear, presumably by apoptosis, as wound healing progresses (1, 2, 4, 5).”
BackgroundKim, S. M., Lim, J. Y., Park, S. I., Jeong, C. H., Oh, J. H., Jeong, M., Oh, W., Park, S.-H., Sung, Y.-C., & Jeun, S.-S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0451 · Cited by 277
“Recently, it has been reported that MSCs could support tumor growth (40) and promote cancer metastasis (41).”
Soria, G., Ofri-Shahak, M., Haas, I., Yaal-Hahoshen, N., Leider-Trejo, L., Leibovich-Rivkin, T., Weitzenfeld, P., Meshel, T., Shabtai, E., Gutman, M., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-130 · Cited by 275
“All four factors are expressed in breast tumors, they exert a diverse array of activities that support malignancy and they were shown to be directly involved in promoting tumor growth and metastasis in animal model systems of breast cancer (Refs [3,5-24] for CCL2 & CCL5, [25-59] for TNFa and IL-1b).”
Peng, D., Tanikawa, T., Li, W., Zhao, L., Vatan, L., Szeliga, W., Wan, S., Wei, S., Wang, Y., Liu, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2528 · Cited by 274
“It is poorly understood if breast CSCs are the primary targets of these cells (10,14,16,17).”
BackgroundCancer stem cells: implications for the progression and treatment of metastatic disease
Croker, A. K., & Allan, A. L. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00211.x · Cited by 273
“Additional studies have shown that other niche cells, such as bone marrow-derived mesenchymal stem cells have been shown to localize to breast carcinomas, and seem to be involved in cancer metastasis [64].”
BackgroundTammi, R. H., Kultti, A., Kosma, V.-M., Pirinen, R., Auvinen, P., & Tammi, M. I. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.005 · Cited by 272
Chowdhury, R., Webber, J. P., Gurney, M., Mason, M. D., Tabi, Z., & Clayton, A. (2015) · Oncotarget · doi:10.18632/oncotarget.2711 · Cited by 272
“In general, MSC which naturally arise at tumour sites or those co-administered with tumours in model systems exhibit similarities to cancer associated stroma in their tumour-promoting effects [15–16, 24–25].”
BackgroundGe, W., Jiang, J., Baroja, M. L., Arp, J., Zassoko, R., Liu, W., Bartholomew, A., Garcia, B., & Wang, H. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02721.x · Cited by 271
“In vivo studies have shown that allogeneic MSCs prolonged skin allograft survival in baboons (28), prevented allogeneic tumor cell rejection in mice (36,37), and attenuated graft-versus-host disease (38,39).”
BackgroundCancer stem cells and their role in metastasis
Shiozawa, Y., Nie, B., Pienta, K. J., Morgan, T. M., & Taichman, R. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.014 · Cited by 268
“It is possible that the EMT process is a critical aspect of CSCs and may not be entirely dependent on outside signals as data suggest that tumor stroma which promote metastasis, may not induce a EMT in tumor cells (Karnoub et al., 2007).”
BackgroundInfluentialBone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer
Raz, Y., Cohen, N., Shani, O., Bell, R. E., Novitskiy, S. V., Abramovitz, L., Levy, C., Milyavsky, M., Leider-Trejo, L., Moses, H. L., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180818 · Cited by 268
“Co-injection of tumor cells with MSCs to immune deficient mice resulted in enhanced tumor growth and metastasis (Karnoub et al., 2007; Mi et al., 2011; Meleshina et al., 2015).”
BackgroundPatient-derived xenograft (PDX) models in basic and translational breast cancer research
Dobrolecki, L. E., Airhart, S. D., Alferez, D. G., Aparicio, S., Behbod, F., Bentires-Alj, M., Brisken, C., Bult, C. J., Cai, S., Clarke, R. B., et al. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9653-x · Cited by 267
“These cells were shown to enhance mammosphere formation in vitro [187, 188] and to stimulate growth and metastasis of established xenografts in vivo [71, 189, 190, 175].”
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Weichand, B., Popp, R., Dziumbla, S., Mora, J., Strack, E., Elwakeel, E., Frank, A.-C., Scholich, K., Pierre, S., Syed, S. N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160392 · Cited by 267
“Two gene expression datasets compared normal with breast tumor stroma (Karnoub et al., 2007; Ma et al., 2009).”
BackgroundMethodInfluentialBattula, V. L., Evans, K. W., Hollier, B. G., Shi, Y., Marini, F. C., Ayyanan, A., Wang, R.-Y., Brisken, C., Guerra, R., Andreeff, M., et al. (2010) · Stem Cells · doi:10.1002/stem.467 · Cited by 266
Chronic inflammation, the tumor microenvironment and carcinogenesis
Gonda, T. A., Tu, S., & Wang, T. C. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8985 · Cited by 265
Fibroblasts as architects of cancer pathogenesis
Marsh, T., Pietras, K., & McAllister, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 264
“Bone marrow-derived MSCs have also been shown to play an important role in tumor progression [58].”
Human Mesenchymal Stem Cells Self-Renew and Differentiate According to a Deterministic Hierarchy
Sarugaser, R., Hanoun, L., Keating, A., Stanford, W. L., & Davies, J. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006498 · Cited by 260
“Sequential loss of the chondrogenic and osteogenic lineages inevitably produce the default fibroblastic lineage not only illustrated in the hierarchy of our model, but also observed in adult marrow stroma, the stromal tissue of the other organs of the body and many solid tumors [54,55].”
BackgroundMSCs: Biological characteristics, clinical applications and their outstanding concerns
Si, Y.-L., Zhao, Y.-L., Hao, H.-J., Fu, X.-B., & Han, W.-D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.005 · Cited by 259
WNT Signaling in Lung Disease: A Failure or a Regeneration Signal?
Königshoff, M., & Eickelberg, O. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0485tr · Cited by 258
“In other cancers, however, the application of MSCs has been shown to promote tumor progression and invasion (176).”
BackgroundZhuang, W.-Z., Lin, Y.-H., Su, L.-J., Wu, M.-S., Jeng, H.-Y., Chang, H.-C., Huang, Y.-H., & Ling, T.-Y. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00725-7 · Cited by 258
Loges, S., Schmidt, T., & Carmeliet, P. (2010) · Genes & Cancer · doi:10.1177/1947601909356574 · Cited by 257
“MSCs also promote metastasis by secreting the chemokine RANTES, which stimulates tumor cell invasiveness.(97) Whether CAFs and MSCs participate in the evasive escape from VEGF-targeted therapy in cancer patients is currently unknown.”
BackgroundModeling tumor phenotypes in vitro with three-dimensional bioprinting
Langer, E. M., Allen-Petersen, B. L., King, S. M., Kendsersky, N. D., Turnidge, M. A., Kuziel, G. M., Riggers, R., Samatham, R., Amery, T. S., Jacques, S. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.090 · Cited by 256
“One such cell type, bone-marrow-derived mesenchymal stem cells (MSCs), has been shown to secrete chemokines, cytokines, growth factors, and ECM proteins that drive increased proliferation and migration of tumor cells and help to establish a metastatic niche (Djouad et al., 2006; Karnoub et al., 2007; Shi et al., 2017;…”
BackgroundCell Therapy: Types, Regulation, and Clinical Benefits
El-Kadiry, A. E.-H., Rafei, M., & Shammaa, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.756029 · Cited by 256
“Albeit to a less documented extent compared to ACT products or other cellular therapies, genetically engineered MSCs have been investigated as a cancer treatment due to their ease of obtainment and demonstrated tumor tropism and anti-tumorigenic properties; however, no benefits have been reported to date with patient-…”
BackgroundMarie-Egyptienne, D. T., Lohse, I., & Hill, R. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.019 · Cited by 256
Cousin, B., Ravet, E., Poglio, S., De Toni, F., Bertuzzi, M., Lulka, H., Touil, I., André, M., Grolleau, J.-L., Péron, J.-M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006278 · Cited by 255
“However, the effects of BM-MSCs on tumor proliferation vary according to the tumor type: BM-MSCs promote breast, melanoma and colon cancer derived cells proliferation [16,17], when inhibit the in vivo growth of Kaposi’s sarcoma cells [18].”
BackgroundConcise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
Lazennec, G., & Jorgensen, C. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1006 · Cited by 255
Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer
Chin, Y. R., & Toker, A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.015 · Cited by 255
Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicine
Satija, N. K., Singh, V. K., Verma, Y. K., Gupta, P., Sharma, S., Afrin, F., Sharma, M., Sharma, P., Tripathi, R. P., & Gurudutta, G. U. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00857.x · Cited by 252
The role of the myofibroblast in tumor stroma remodeling
Otranto, M., Sarrazy, V., Bonté, F., Hinz, B., Gabbiani, G., & Desmouliere, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20377 · Cited by 250
“MSCs that have become activated by mildly invasive human breast carcinoma cells in culture enhance the metastatic potential of the cancer cells when injected subcutaneously; this effect is mediated in a paracrine feedback loop.(143) In contrast, other studies did not confirm myofibroblast activation of BM-MSCs in the…”
Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (I)
Bello, I. O., Soini, Y., & Salo, T. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.06.006 · Cited by 250
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
“Additionally, CCL5 expression is upregulated in MSCs from prostate cancer and breast cancer cell lines.”
BackgroundInfluentialStromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation
Buckley, C. D., Barone, F., Nayar, S., Bénézech, C., & Caamaño, J. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120252 · Cited by 249
Bexell, D., Gunnarsson, S., Tormin, A., Darabi, A., Gisselsson, D., Roybon, L., Scheding, S., & Bengzon, J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.229 · Cited by 248
Garrido-Laguna, I., Uson, M., Rajeshkumar, N. V., Tan, A. C., de Oliveira, E., Karikari, C., Villaroel, M. C., Salomon, A., Taylor, G., Sharma, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0341 · Cited by 247
“This mechanism is not disease specific as mesenchymal stem cells within the stroma promote breast cancer growth and metastases (27).”
BackgroundÖzdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.002 · Cited by 245
Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis
Shu, L., Cheung, K.-L., Khor, T. O., Chen, C., & Kong, A.-N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9239-y · Cited by 245
Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization
Suzuki, K., Sun, R., Origuchi, M., Kanehira, M., Takahata, T., Itoh, J., Umezawa, A., Kijima, H., Fukuda, S., & Saijo, Y. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00157 · Cited by 244
“Several studies have used human MSCs, as opposed to murine MSCs, to assess the effects of this cell type on tumor growth in mouse models because of the ease of expansion of human MSCs (3,24).”
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
The double edge sword of fibrosis in cancer
Chandler, C., Liu, T., Buckanovich, R., & Coffman, L. G. (2019) · Translational Research · doi:10.1016/j.trsl.2019.02.006 · Cited by 242
“This may explain much of the divergent results depending on the tissue source of the stromal cells studied.(59,132,156) Also, as the timing and spatial magnitude of cancer reprogramming is unknown, stroma found within in situ or premalignant lesions may not have undergone cancer education and may still maintain a norm…”
BackgroundResultAugsten, M., Hägglöf, C., Olsson, E., Stolz, C., Tsagozis, P., Levchenko, T., Frederick, M. J., Borg, Å., Micke, P., Egevad, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813144106 · Cited by 242
“Additionally, mesenchymal stem cell–derived CCL5/ RANTES was recently shown to confer prometastatic effects on breast cancer cells (8).”
BackgroundStonesifer, C., Corey, S., Ghanekar, S., Diamandis, Z., Acosta, S. A., & Borlongan, C. V. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.004 · Cited by 241
“Moreover, the potential tumorigenic risks of BM-MSC transplantation deserve further examination (Karnoub et al., 2007; Subramanian et al., 2012).”
InfluentialLatifi, A., Luwor, R. B., Bilandzic, M., Nazaretian, S., Stenvers, K., Pyman, J., Zhu, H., Thompson, E. W., Quinn, M. A., Findlay, J. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046858 · Cited by 240
“MSC have also been shown to induce EMT and CSC in breast tumor cells [31–32], and shown to affect metastasis [33].”
BackgroundZhang, J., & Wang, J. H. (2010) · Journal of Orthopaedic Research · doi:10.1002/jor.21046 · Cited by 240
“However, accumulating evidence has pointed to the prominent role of adult stem cells in tissue pathologies, such as tumorigenesis.(20) We therefore suspect that TSCs play a major pathogenic role in the development of tendinopathy.”
BackgroundIdentification, discrimination and heterogeneity of fibroblasts
Lendahl, U., Muhl, L., & Betsholtz, C. (2022) · Nature Communications · doi:10.1038/s41467-022-30633-9 · Cited by 239
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Mishra, P., Banerjee, D., & Ben-Baruch, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310182 · Cited by 239
Chaturvedi, P., Gilkes, D. M., Wong, C. C. L., Kshitiz, Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64993 · Cited by 238
“MSCs exhibit homing to sites of tissue injury and tumor growth (31–33).”
InfluentialThe Tumor Microenvironment in Colorectal Carcinogenesis
Peddareddigari, V. G., Wang, D., & DuBois, R. N. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0038-3 · Cited by 237
“They also promote tumor growth and metastasis [238], in part by their immunosuppressive”
BackgroundSnail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression
de Herreros, A. G., Peiró, S., Nassour, M., & Savagner, P. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9179-8 · Cited by 237
“In the case of TGF-, this cytokine might be a product of the cancer activated fibroblasts present in the tumoral stroma (115) and contribute together with intrinsic signals to the induction of an EMT in tumor cells.”
BackgroundChu, D.-T., Phuong, T. N. T., Tien, N. L. B., Tran, D. K., Thanh, V. V., Quang, T. L., Truong, D. T., Pham, V. H., Ngoc, V. T. N., Chu-Dinh, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030708 · Cited by 236
“In vitro and in vivo studies have reported stimulation of tumor growth by providing supportive stroma, creating a permissive environment and/or reducing immune rejection of tumor cells [127,128].”
BackgroundKauer, T. M., Figueiredo, J.-L., Hingtgen, S., & Shah, K. (2012) · Nature Neuroscience · doi:10.1038/nn.3019 · Cited by 236
“Note: Supplementary information is available on the Nature Neuroscience website.”
Transforming growth factor β as regulator of cancer stemness and metastasis
Bellomo, C., Caja, L., & Moustakas, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.255 · Cited by 235
“…can be generated from bone marrow-derived mesenchymal stem cells (BM-MSC), which can be recruited at the tumour or inflammatory site and be committed to fibroblast differentiation by the locally released cytokines and growth factors (Karnoub et al, 2007; Mishra et al, 2008; Quante et al, 2011).”
BackgroundMolecular mechanisms of metastasis in breast cancer—clinical applications
Mego, M., Mani, S. A., & Cristofanilli, M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.171 · Cited by 235
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Zhang, T., Lee, Y. W., Rui, Y. F., Cheng, T. Y., Jiang, X. H., & Li, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt221 · Cited by 234
“The mutual interactions between tumor cells and stromal cells via direct contact or through the production of growth factors, cytokines and chemokines in a paracrine manner are thought to modulate tumor expansion, invasion, metastasis and angiogenesis [2,4-9].”
BackgroundExosome: emerging biomarker in breast cancer
Jia, Y., Chen, Y., Wang, Q., Jayasinghe, U., Luo, X., Wei, Q., Wang, J., Xiong, H., Chen, C., Xu, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16684 · Cited by 234
Zhang, Y., Daquinag, A. C., Amaya-Manzanares, F., Sirin, O., Tseng, C., & Kolonin, M. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0294 · Cited by 233
“org Cancer Res; 72(20) October 15, 2012 5203”
BackgroundInfluentialRecent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Jiao, X., Nawab, O., Patel, T., Kossenkov, A. V., Halama, N., Jaeger, D., & Pestell, R. G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1167 · Cited by 232
“For example,MSCs produce CCL3, CCCL4, and CCL5 and when mixed with either breast (47), or colon cancer cells (53), they promoted tumormetastasis.”
BackgroundInfluentialBarcellos-de-Souza, P., Comito, G., Pons-Segura, C., Taddei, M. L., Gori, V., Becherucci, V., Bambi, F., Margheri, F., Laurenzana, A., Del Rosso, M., et al. (2016) · Stem Cells · doi:10.1002/stem.2412 · Cited by 230
Wang, M., Zhao, C., Shi, H., Zhang, B., Zhang, L., Zhang, X., Wang, S., Wu, X., Yang, T., Huang, F., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.14 · Cited by 230
“Accumulating evidence has demonstrated that interactions between bone marrow-derived mesenchymal stem cells (BM-MSCs) and cancer cells endow the latter with proliferative, invasive and metastatic properties (Karnoub et al, 2007; Roorda et al, 2009; Bergfeld and DeClerck, 2010; Yang et al, 2013).”
BackgroundCurrent and future immunotherapeutic approaches in pancreatic cancer treatment
Farhangnia, P., Khorramdelazad, H., Nickho, H., & Delbandi, A.-A. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01561-6 · Cited by 229
Is Cancer a Metabolic Disease?
Coller, H. A. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.035 · Cited by 229
“Stromal cells, for example, the fibroblasts, in the tumor microenvironment can actively support malignant transformation(88) and metastasis.(89) A hypothesis has been proposed that the tumor stroma is glycolytic and that stromal cells express MCTs that exude lactate, whereas tumor cells perform oxidative metabolism an…”
BackgroundInflammatory chemokines and metastasis—tracing the accessory
Borsig, L., Wolf, M. J., Roblek, M., Lorentzen, A., & Heikenwalder, M. (2014) · Oncogene · doi:10.1038/onc.2013.272 · Cited by 229
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 229
“Among these cells, adipocytes are found to secret hepatocyte growth factor (HGF) to promote tumor growth [117] and endothelial cells play roles in angiogenesis and cancer cell dissemination [118, 119].”
BackgroundStudebaker, A. W., Storci, G., Werbeck, J. L., Sansone, P., Sasser, A. K., Tavolari, S., Huang, T., Chan, M. W. Y., Marini, F. C., Rosol, T. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0400 · Cited by 229
Decreased expression of miR‐125b and miR‐100 in oral cancer cells contributes to malignancy
Henson, B. J., Bhattacharjee, S., O'Dee, D. M., Feingold, E., & Gollin, S. M. (2009) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20666 · Cited by 229
“, 2008), breast cancer (Karnoub et al., 2007), prostate cancer (Robinson et al.”
BackgroundConcise Review: Mesenchymal Stem Cell Tumor-Homing: Detection Methods in Disease Model Systems
Reagan, M. R., & Kaplan, D. L. (2011) · Stem Cells · doi:10.1002/stem.645 · Cited by 229
Luo, W., Chang, R., Zhong, J., Pandey, A., & Semenza, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217394109 · Cited by 228
“Stromal cells play important roles in primary tumor growth and progression (44).”
BackgroundMesenchymal stem cells promote growth and angiogenesis of tumors in mice
Huang, W.-H., Chang, M.-C., Tsai, K.-S., Hung, M.-C., Chen, H.-L., & Hung, S.-C. (2013) · Oncogene · doi:10.1038/onc.2012.458 · Cited by 227
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
“CSF1→CSF1R→EGF→EGF receptor (BCC-TAM) signaling (14–16), CCL5→CCR5 (MSC-BCC) signaling (6), and PGF→VEGFR1→CXCL10→CXCR3 (BCC-MSC) signaling (9) were described previously.”
BackgroundWeber, C. E., Kothari, A. N., Wai, P. Y., Li, N. Y., Driver, J., Zapf, M. A. C., Franzen, C. A., Gupta, G. N., Osipo, C., Zlobin, A., et al. (2015) · Oncogene · doi:10.1038/onc.2014.410 · Cited by 226
Zimmerlin, L., Donnenberg, A. D., Rubin, J. P., Basse, P., Landreneau, R. J., & Donnenberg, V. S. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0248 · Cited by 225
“29 32 These experiments were performed exclusively using rapidly growing cell lines that fail to model the natural history of breast cancer, where residual tumor may remain dormant, 17,33 only to reactivate years after apparently successful therapy.”
Non-genetic engineering of cells for drug delivery and cell-based therapy
Wang, Q., Cheng, H., Peng, H., Zhou, H., Li, P. Y., & Langer, R. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.003 · Cited by 225
Yu, P. F., Huang, Y., Han, Y. Y., Lin, L. Y., Sun, W. H., Rabson, A. B., Wang, Y., & Shi, Y. F. (2017) · Oncogene · doi:10.1038/onc.2016.217 · Cited by 225
Cho, J. A., Park, H., Lim, E. H., Kim, K. H., Choi, J. S., Lee, J. H., Shin, J. W., & Lee, K. W. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.08.005 · Cited by 225
“An important study reportedan interaction betweenMSCs and cancer cells in tumor progression and malignancy by demonstrating that MSCswithin the tumor stroma are the promoters for breast tumor metastasis [18].”
BackgroundResultWong, C. C.-L., Zhang, H., Gilkes, D. M., Chen, J., Wei, H., Chaturvedi, P., Hubbi, M. E., & Semenza, G. L. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0855-y · Cited by 225
“Increasing evidence reveals that stromal cells such as fibroblasts, mesenchymal stem cells, vascular cells, and inflammatory cells, which are recruited into the primary tumor, facilitate cancer progression and metastasis [21].”
Hossain, A., Gumin, J., Gao, F., Figueroa, J., Shinojima, N., Takezaki, T., Priebe, W., Villarreal, D., Kang, S.-G., Joyce, C., et al. (2015) · Stem Cells · doi:10.1002/stem.2053 · Cited by 224
Ma, C., Rong, Y., Radiloff, D. R., Datto, M. B., Centeno, B., Bao, S., Cheng, A. W. M., Lin, F., Jiang, S., Yeatman, T. J., et al. (2008) · Genes & Development · doi:10.1101/gad.1632008 · Cited by 224
“…VE-cadherin junction dissociation requires integrin v 5 As a secreted protein containing multiple integrin-interacting domains, ig-h3 has been shown to interact with various types of integrins, including v 3, v 5, 3 1, and 6 4 (Bae et al. 2002; Kim et al. 2003; Nam et al. 2003; Lee et al. 2006).”
BackgroundCantinieaux, D., Quertainmont, R., Blacher, S., Rossi, L., Wanet, T., Noël, A., Brook, G., Schoenen, J., & Franzen, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069515 · Cited by 223
“[35,36], and have a limited ability to replace lost cells [23,37,38]; finally, when used in other pathological contexts, BMSC transplants can have various adverse effects [39-44].”
BackgroundHuman cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
van Staveren, W. C. G., Solís, D. Y. W., Hébrant, A., Detours, V., Dumont, J. E., & Maenhaut, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.004 · Cited by 222
Chiavarina, B., Whitaker-Menezes, D., Migneco, G., Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Tanowitz, H. B., Casimiro, M. C., Wang, C., Pestell, R. G., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12908 · Cited by 222
“For example, cancer-associated fibroblasts can induce an EMT in normal epithelial cells,(6) and via this mechanism, they can also promote cancer cell metastasis to distant organ sites.(7,8)”
BackgroundExperimental models of hepatocellular carcinoma
Newell, P., Villanueva, A., Friedman, S. L., Koike, K., & Llovet, J. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.008 · Cited by 222
“Additional advances have been made in the xenograft model through the addition of mesenchymal stem cells to weakly metastatic cancer cell lines, which enhances the ability of the cell lines to form tumors and to metastasize [17].”
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Ojalvo, L. S., King, W., Cox, D., & Pollard, J. W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080676 · Cited by 221
Gu, J., Qian, H., Shen, L., Zhang, X., Zhu, W., Huang, L., Yan, Y., Mao, F., Zhao, C., Shi, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052465 · Cited by 220
“Tumor microenvironment is composed of diverse types of cells, including carcinoma-associated fibroblasts (CAFs), infiltrating immune cells, blood and lymphatic vascular networks, and mesenchymal stem cells (MSCs) [4,5].”
BackgroundStem cell-based therapies for cancer treatment: separating hope from hype
Stuckey, D. W., & Shah, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3798 · Cited by 220
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
El-Haibi, C. P., Bell, G. W., Zhang, J., Collmann, A. Y., Wood, D., Scherber, C. M., Csizmadia, E., Mariani, O., Zhu, C., Campagne, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206653109 · Cited by 218
“Because the protumorigenic and prometastatic functions of stromal MSCs have now been recognized in multiple tumor settings (7, 38), it would be important to exploit such a platform to further characterize the molecular nature of the heterotypic cross-talk that takes place at the tumor to stroma…”
BackgroundInfluentialSelf-citationChu, D.-T., Nguyen, T. T., Tien, N. L. B., Tran, D.-K., Jeong, J.-H., Anh, P. G., Thanh, V. V., Truong, D. T., & Dinh, T. C. (2020) · Cells · doi:10.3390/cells9030563 · Cited by 216
Clouet, J., Fusellier, M., Camus, A., Le Visage, C., & Guicheux, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.017 · Cited by 216
Eychène, A., Rocques, N., & Pouponnot, C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2460 · Cited by 215
Chemokines in cancer related inflammation
Allavena, P., Germano, G., Marchesi, F., & Mantovani, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.013 · Cited by 215
“stromal-derived CCL5 then interacted with CCR5-positive tumor cells enhancing their growth in vivo and metastatic ability [116].”
BackgroundCell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review
He, Z., Zhang, Y., & Feng, N. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110298 · Cited by 215
Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model
Sun, B., Roh, K.-H., Park, J.-R., Lee, S.-R., Park, S.-B., Jung, J.-W., Kang, S.-K., Lee, Y.-S., & Kang, K.-S. (2009) · Cytotherapy · doi:10.1080/14653240902807026 · Cited by 214
Metadata
- Authors
- Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-10-04
- Volume
- 449
- Issue
- 7162
- Pages
- 557-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2141815918
- Cited by
- 3,206
- References
- 36
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 95 · 2023: 137 · 2022: 144 · 2021: 186 · 2020: 192 · 2019: 153 · 2018: 145 · 2017: 176 · 2016: 182 · 2015: 222 · 2014: 232 · 2013: 232 · 2012: 216
- FWCI
- 89.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA089393, R01CA116235)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- mesenchymal stem cells, breast cancer metastasis, tumor stroma, RANTES, CCR5, paracrine signaling, tumor cell motility, tumor invasion, tumor microenvironment, bone marrow-derived stem cells, tumor xenografts
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Fibroblasts, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Transplantation, Mice, SCID, Mice, Inbred NOD, Stromal Cells, Carcinoma, Ductal, Breast, Chemokine CCL5, Receptors, CCR5, Chemokines, CC, Paracrine Communication, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.